<DOC>
	<DOCNO>NCT01641120</DOCNO>
	<brief_summary>The purpose study evaluate patient ' view inject Avonex intramuscularly .</brief_summary>
	<brief_title>Assessing Tolerability Avonex Intramuscular Injections</brief_title>
	<detailed_description />
	<mesh_term>Sclerosis</mesh_term>
	<mesh_term>Multiple Sclerosis</mesh_term>
	<mesh_term>Interferon-beta</mesh_term>
	<mesh_term>Interferon beta-1a</mesh_term>
	<criteria>Between 18 65 year age ; Confirmed diagnosis Relapsing Remitting Multiple Sclerosis ; Currently treat Avonex速 least 90 day ; Using 25 gauge needle injection Avonex速 least 90 day ; Willing able complete study questionnaire ; Provided inform consent participate study Diagnosis Progressive Multiple Sclerosis ; History recent illness infection ; History allergic reaction Avonex速 ; Any prior usage 30 gauge needle administration Avonex速 ; Concurrent treatment immunomodulating therapy ; Pregnant plan become pregnant ; Nursing mother ; Unable complete requirement study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>December 2015</verification_date>
	<keyword>Multiple Sclerosis</keyword>
	<keyword>Intramuscular Injections</keyword>
	<keyword>Relapsing Remitting</keyword>
</DOC>